Differences in HCV viral decline between low and standard-dose pegylated-interferon-alpha-2a with ribavirin in HIV/HCV genotype 3 patients.

Differences in HCV viral decline between low and standard-dose pegylated-interferon-alpha-2a with ribavirin in HIV/HCV genotype 3 patients.

The aim of the study was to analyze the different impact of standard and low-dose Peg-IFN-α2a/RBV therapies on HCV viral decline in HIV/HCV genotype 3 co-infected patients during the first weeks of treatment.Plasma HCV viral decline was analyzed between baseline and weeks 1, 2 and 4 in two groups of...

Full description

Bibliographic Details
Main Authors: Antonio Rivero-Juárez, Luis F Lopez-Cortes, Angela Camacho, Almudena Torres-Cornejo, Juan A Pineda, Manuel Marquez-Solero, Antonio Caruz, Rosa Ruiz-Valderas, Julian Torre-Cisneros, Alicia Gutierrez-Valencia, Antonio Rivero
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3493612?pdf=render

Internet

http://europepmc.org/articles/PMC3493612?pdf=render

Similar Items